COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
A Fendler, EGE de Vries… - Nature Reviews …, 2022 - nature.com
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …
associated mortality than the general population. Owing to this increased risk, patients with …
[HTML][HTML] Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
E Amanatidou, A Gkiouliava, E Pella, M Serafidi… - Metabolism open, 2022 - Elsevier
Vaccination programs against SARS-CoV-2 constitute the mainstay of public health
interventions against the global COVID-19 pandemic. Currently available vaccines have …
interventions against the global COVID-19 pandemic. Currently available vaccines have …
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
ZL Brumme, F Mwimanzi, HR Lapointe, PK Cheung… - npj Vaccines, 2022 - nature.com
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …
[HTML][HTML] Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
IATM Ferreira, CYC Lee, WS Foster, A Abdullahi… - Cell Reports, 2023 - cell.com
Suboptimal responses to a primary vaccination course have been reported in the elderly, but
there is little information regarding the impact of age on responses to booster third doses …
there is little information regarding the impact of age on responses to booster third doses …
Age-associated alterations in immune function and inflammation
ED Lewis, D Wu, SN Meydani - Progress in Neuro-Psychopharmacology …, 2022 - Elsevier
Immunosenescence is a term used to describe the age-related changes in the immune
system. Immunosenescence is associated with complex alterations and dysregulation of …
system. Immunosenescence is associated with complex alterations and dysregulation of …
Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose
F Mwimanzi, HR Lapointe, PK Cheung… - The Journal of …, 2022 - academic.oup.com
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …
COVID-19 vaccine immunogenicity in people with HIV
CT Costiniuk, J Singer, T Lee, MA Langlois, C Arnold… - Aids, 2023 - journals.lww.com
COVID-19 vaccine immunogenicity in people with HIV : AIDS COVID-19 vaccine immunogenicity
in people with HIV : AIDS Log in or Register Subscribe to journalSubscribe Get new issue …
in people with HIV : AIDS Log in or Register Subscribe to journalSubscribe Get new issue …
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
ME Toledo-Romani, M García-Carmenate… - Med, 2022 - cell.com
Background SOBERANA 02 has been evaluated in phase I and IIa studies comparing
homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we …
homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we …
Humoral responses against SARS-CoV-2 and variants of concern after mRNA vaccines in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia
PURPOSE Patients with non-Hodgkin lymphoma including chronic lymphocytic leukemia
(NHL/CLL) are at higher risk of severe SARS-CoV-2 infection. We investigated vaccine …
(NHL/CLL) are at higher risk of severe SARS-CoV-2 infection. We investigated vaccine …
Characterization of serum and mucosal SARS-CoV-2-antibodies in HIV-1-infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infection
KG Schmidt, EG Harrer, K Tascilar, S Kübel, B El Kenz… - Viruses, 2022 - mdpi.com
Only limited data are available regarding the immunogenicity of the BNT162b2 mRNA
vaccine in HIV-1+ patients. Therefore, we investigated the humoral immune response after …
vaccine in HIV-1+ patients. Therefore, we investigated the humoral immune response after …